BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1553 related articles for article (PubMed ID: 32106567)

  • 1. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
    Ahmed SF; Quadeer AA; McKay MR
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
    J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
    Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M
    Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
    Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB
    Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain:
    Chukwudozie OS; Chukwuanukwu RC; Iroanya OO; Eze DM; Duru VC; Dele-Alimi TO; Kehinde BD; Bankole TT; Obi PC; Okinedo EU
    J Immunol Res; 2020; 2020():2837670. PubMed ID: 32964056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2.
    Kalita P; Padhi AK; Zhang KYJ; Tripathi T
    Microb Pathog; 2020 Aug; 145():104236. PubMed ID: 32376359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.
    Naz A; Shahid F; Butt TT; Awan FM; Ali A; Malik A
    Front Immunol; 2020; 11():1663. PubMed ID: 32754160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbiased Screens Show CD8
    Ferretti AP; Kula T; Wang Y; Nguyen DMV; Weinheimer A; Dunlap GS; Xu Q; Nabilsi N; Perullo CR; Cristofaro AW; Whitton HJ; Virbasius A; Olivier KJ; Buckner LR; Alistar AT; Whitman ED; Bertino SA; Chattopadhyay S; MacBeath G
    Immunity; 2020 Nov; 53(5):1095-1107.e3. PubMed ID: 33128877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2.
    Rakib A; Sami SA; Islam MA; Ahmed S; Faiz FB; Khanam BH; Marma KKS; Rahman M; Uddin MMN; Nainu F; Emran TB; Simal-Gandara J
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33147821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
    Vashi Y; Jagrit V; Kumar S
    Infect Genet Evol; 2020 Oct; 84():104382. PubMed ID: 32473352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
    Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
    Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A candidate multi-epitope vaccine against SARS-CoV-2.
    Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP
    Sci Rep; 2020 Jul; 10(1):10895. PubMed ID: 32616763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.
    Khalaj-Hedayati A
    J Immunol Res; 2020; 2020():7201752. PubMed ID: 32695833
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lee CH; Koohy H
    F1000Res; 2020; 9():145. PubMed ID: 32269766
    [No Abstract]   [Full Text] [Related]  

  • 19. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
    Ahammad I; Lira SS
    Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.